Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.
PAR
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.04Â ( -9.09%)
Relative Strenght
Volume Buzz
107%
Earning Acce
Yes
Dist 52w H.
88%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ALCAR.PA compares to sector?
Relative Strength
ALCAR.PA
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
271%2025-Revenue
47%2025-EPS
67%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Earnings Growth
YoY
Current
Estimates
Q2.21
N/A
-1.71
vs -1.65
Q4.21
N/A
-2.28
vs -1.24
Q2.22
N/A
-1.32
vs -1.71
Q4.22
N/A
-1.22
vs -2.28
Q2.23
N/A
-1.17
vs -1.32
Q4.23
N/A
-1.19
vs -1.22
Q2.24
N/A
-1.15
vs -1.17
Q4.24
N/A
-1.11
vs -1.19
Q2.25
N/A
-0.17
vs -1.15
Q3.25
N/A
-0.13
vs NA
Sales Growth
YoY
Current
Estimates
Q2.21
NA
NA vs NA
Q4.21
+24667%
2.2M vs 9K
Q2.22
NA
3K vs NA
Q4.22
-85%
342K vs 2.2M
Q2.23
+18333%
553K vs 3K
Q4.23
+557%
2.2M vs 342K
Q2.24
+497%
3.3M vs 553K
Q4.24
+65%
3.7M vs 2.2M
Q2.25
-9%
3M vs 3.3M
Q3.25
NA
5.1M vs NA
Return on Equity
QoQ
Q2.21
-138%
-1.38
vs -2.06
Q4.21
+259%
2.59
vs -1.38
Q2.22
+18750%
187.5
vs 2.59
Q4.22
-1680%
-16.80
vs 187.5
Q2.23
+107%
1.07
vs -16.80
Q4.23
+62%
0.62
vs 1.07
Q2.24
+116%
1.16
vs 0.62
Q4.24
+49%
0.49
vs 1.16
Institutionnal Ownership